Biology voices weigh in on the impact of AI on drug discovery from the largest NeurIPS research conference to date.

BenchSci, a leading provider of AI software for biopharma research and development, today announced a renewed two-year contract with Merck, known as MSD outside of the United States and Canada.“Seeing ...

Databricks VP Naveen Rao, aims to design new hardware and a software system inspired by biological intelligence.

Modern biology runs on precision, yet so much of the daily lab workflow remains stubbornly manual. Even today, one of ...

Backed by Andreessen Horowitz and Jeff Bezos, Unconventional AI wants to ditch GPUs for biologically inspired hardware that ...

Researchers demonstrated that it is feasible to encode executable payloads into synthetic DNA that, once sequenced and ...

Drug development in biotechnology takes time. A lot of time. On average, it takes 10 to 15 years to take a medicine from ...

Male broad-tailed hummingbirds sync speed, sound, and flashing colors in a 300-millisecond dive that dazzles females during ...

HeartBeam, iBio, Momentus and are the 3 Penny Stocks to watch on December 11. 2025, based on TipRanks’ Penny Stock Screener ...

Amazon.com Inc. (NASDAQ:AMZN) founder Jeff Bezos used his final letter to shareholders as chief executive to deliver an ...

A new study from UNC-Chapel Hill researchers shows that advanced artificial intelligence tools, specifically large language ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...